PD-L1 expression was reported to be over expressed in MMR-deficient cancers, usually because MMR-deficient cancer creates high accumulated mutations which lead many tumor-specific neoantigens and is associated with high immune activities presumably aroused by mutated neoantigens. The gene discussed is CD274; the disease is neoplasm.